Menu

rss
BMJ Case Reports 2012; doi:10.1136/bcr-2012-006339
  • Rare disease

Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies

  1. Hanul Srinivas Bhandari
  1. Department of Neurology, UT Southwestern Med Ctr, Austin, Texas, USA
  1. Correspondence to Dr Hanul Srinivas Bhandari, hbhand{at}mednet.swmed.edu

In this rare case, the patient presented with opsoclonus, myoclonus and ataxia. Serological and imaging studies revealed high glutamic acid decarboxylase antibody (GAD-Ab) levels. High-dose corticosteroids were of no benefit and subsequent intravenous immunoglobulin (IVIg) administration proved resolution of the condition. Levetiracetam proved useful in symptomatically controlling the myoclonus. Follow-up GAD-Ab levels were within normal limits.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

This Article

  1. Summary
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Top rated cases

Top rated cases

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

 

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog